Delafloxacin: A New Anti-methicillin-resistant Staphylococcus aureus Fluoroquinolone

Abstract Delafloxacin (ABT 492) is a new fluoroquinolone available in both oral and parenteral formulations. It has recently been approved by the Food and Drug Administration for the management of acute bacterial skin and skin structure infections. When compared to combination therapy of vancomycin...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical infectious diseases 2019-03, Vol.68 (6), p.1058-1062
Hauptverfasser:	Saravolatz, Louis D, Stein, Gary E
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Drug Resistance, Bacterial Fluoroquinolones - chemistry Fluoroquinolones - pharmacology Fluoroquinolones - therapeutic use Humans Methicillin-Resistant Staphylococcus aureus - drug effects Microbial Sensitivity Tests Staphylococcal Infections - drug therapy Staphylococcal Infections - microbiology Structure-Activity Relationship Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!